Jennifer Pietenpol

  • Initiative set to sharpen VUMC’s strategic focus

    Initiative set to sharpen VUMC’s strategic focus

    With the transition of Vanderbilt University Medical Center (VUMC) into a new financial and legal entity now complete, Medical Center leaders view this period as an opportunity to sharpen the organization’s strategic focus. Read More

    Jul 14, 2016

  • Aerial view of Kirkland Tower and campus (Vanderbilt University)

    13 cross-college collaborative projects win TIPs funding

    Thirteen interdisciplinary projects, ranging from cellular processes and smart cities to global health care issues, have been selected as the 2016 awardees of the Trans-Institutional Program (TIPs) initiative. Read More

    Jun 2, 2016

  • Vanderbilt University

    Precision medicine already changing cancer treatment strategies

    The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. Read More

    May 26, 2016

  • Vanderbilt University

    Public invited to learn about VICC precision cancer medicine

    Leading cancer investigators from Vanderbilt-Ingram Cancer Center will unveil the latest in cancer research during a community event May 10. Read More

    Apr 27, 2016

  • Vanderbilt University

    Pietenpol named Executive Vice President for Research

    Jennifer Pietenpol, Ph.D., director of the Vanderbilt-Ingram Cancer Center, B.F. Byrd Jr. Professor of Molecular Oncology and Professor of Biochemistry, Cancer Biology and Otolaryngology, has been named Executive Vice President for Research at Vanderbilt University Medical Center (VUMC). Her appointment is effective May 1. Read More

    Apr 14, 2016

  • Vanderbilt University

    Pietenpol named to NCI Blue Ribbon Panel

    Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), has been selected to serve on a Blue Ribbon Panel that will inform the scientific direction and goals at the National Cancer Institute (NCI) for Vice President Joe Biden’s National Cancer Moonshot Initiative. Read More

    Apr 7, 2016

  • DNA sequence visualization

    New role identified for p73 gene

    The p73 gene is required for the generation of cilia – hair-like projections on cells – findings that could have implications for the study of lung diseases and sterility. Read More

    Apr 1, 2016

  • Vanderbilt University

    T.J. Martell Foundation lauds Pietenpol’s research

    Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), was honored with the Medical Research Advancement Award during the 8th Annual T.J. Martell Foundation Nashville Honors Gala held recently at the Omni Nashville Hotel. Read More

    Mar 17, 2016

  • Vanderbilt University

    Komen, VICC partnership bolsters breast cancer research

    For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support. Read More

    Oct 8, 2015

  • VICC investigators land Komen breast cancer grants

    VICC investigators land Komen breast cancer grants

    Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. Read More

    Oct 1, 2015

  • Vanderbilt University

    Strong scores put VICC among top NCI centers

    Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). Read More

    Sep 17, 2015

  • Vanderbilt University

    VICC investigators earn breast cancer grants

    The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies. Read More

    Oct 23, 2014

  • Vanderbilt University

    Pietenpol named to IOM Cancer Policy Forum

    Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies. Read More

    Jul 10, 2014

  • Vanderbilt University

    VICC receives $100,000 ovarian cancer research grant

    The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center. Read More

    Jan 21, 2014

  • Vanderbilt University

    VICC debuts new Center for Cancer Targeted Therapies

    Vanderbilt-Ingram Cancer Center leaders formally dedicated the space for the new Center for Cancer Targeted Therapies (CCTT), located in the Infusion Center on the second floor of The Vanderbilt Clinic, at a special ribbon-cutting held during last week’s fall meeting of the Cancer Center’s Board of Overseers. Read More

    Oct 31, 2013

  • Vanderbilt University

    Komen grants bolster breast cancer research

    Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research. Read More

    Aug 15, 2013

  • Vanderbilt University

    West Tennessee Healthcare and Vanderbilt University Medical Center announce academic affiliation agreement

    Kirkland Cancer Center Leaders of West Tennessee Healthcare (WTH) and Vanderbilt University Medical Center today announced an academic affiliation agreement which further establishes a collaborative relationship between the two institutions, now for the creation of new cancer programs in West Tennessee. The new agreement creates a… Read More

    May 21, 2013

  • Vanderbilt University

    Record number elected AAAS fellows

    Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read More

    Nov 29, 2012

  • The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)

    Cancer research and education agreement announced between Baptist Memorial Health Care and Vanderbilt University

    Executives with Baptist Memorial Health Care Corporation in Memphis, Tenn., and Vanderbilt University Medical Center today announced an academic affiliation agreement — paving the way for new clinical research and academic education opportunities that are designed to enhance cancer programs. The new affiliation establishes a framework… Read More

    Oct 29, 2012

  • genetic sequence

    Vanderbilt cancer investigators win two national GE cancer research grants

    Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” Read More

    Mar 28, 2012